LDM Group and NextGen Healthcare Partner to Provide Clinically Relevant Healthcare Messages to Improve Medication Adherence

LDM Group and NextGen Healthcare Partner to Provide Clinically Relevant Healthcare Messages to Improve Medication Adherence

<0> LDM Group, LLCSuzanne Corcoran, 484-530-4870 x 19 </0>

LDM Group, LLC, a leading targeted healthcare communications company, announced today that NextGen Healthcare will offer LDM’s clinically relevant healthcare messaging programs to its ambulatory Electronic Health Record (EHR) clients. Under the agreement, NextGen Healthcare will offer LDM’s patented messaging platform to its network of providers and patients through various NextGen® EHR applications.

LDM provides real-time, clinically relevant healthcare messaging, which helps improve patient medication adherence and overall health outcomes while preserving patient privacy. LDM will provide this clinically relevant information through its patented and certified ConnectSys® 3.0 system, which supports LDM’s portfolio of messaging programs at the point-of-care.

In a recent study, the IMS Institute for Healthcare Informatics found that better adherence and more careful prescribing of antibiotics could reduce total annual health expenditures in the U.S. by eight percent. LDM’s medication adherence programs, which are disseminated by the health care provider, are produced in real-time as the prescription is being ordered during a physician-patient consultation. The programs enhance the physician-patient dialogue by providing personalized messaging and the impetus for the patient to fill their prescription. LDM’s services provide value to both the prescribers and the patients during the “teachable moment” at the point of care.

“We are excited to partner with NextGen as both organizations continually strive to find innovative ways to engage patients in their care by taking a proactive role in their health,” said Mark Heinold, CEO of LDM Group.

NextGen Healthcare and LDM will work together to create additional product offerings that serve to increase patient compliance centered around medications and chronic disease states, increasing overall population health and resulting in more informed patients. By integrating LDM’s interactive solutions, NextGen Healthcare demonstrates the company’s commitment to improving patient drug safety by offering the most critical drug information needed, concisely and conveniently within workflow, at the point of prescribing.

“This partnership with LDM further demonstrates our commitment to improving health outcomes by providing clinically relevant content to patients at the point of care,” said Gene DuAime, Vice President of Data and Analytics for NextGen Healthcare.

LDM Group, LLC (LDM) is a leading provider of behavior based prescription management programs. As a targeted healthcare communication company, LDM connects prescribers, pharmacists, and patients. LDM’s network is made up of e-prescribing, electronic medical record (EMR), and electronic health record (EHR) applications, chain and independent pharmacies, and sponsors of healthcare related educational materials. LDM provides timely and clinically relevant healthcare messaging through its patented and certified process which serves to improve patient compliance, persistence and outcomes, while preserving privacy. For more information, please visit .

NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality Systems, Inc., provides integrated clinical, connectivity and financial solutions, including revenue cycle management services for ambulatory, inpatient and dental provider organizations. For more information, please visit and . Follow NextGen Healthcare on Twitter at , Facebook at or LinkedIn at .

Suggested Articles

Errors in diagnostic tests and medication safety events pose the biggest risk to patients in ambulatory care settings, according to a new analysis.

Healthcare innovation network AVIA has secured $22 million in its latest funding round.

The growing role of data in our lives raises important questions about data access and ownership. Who rightfully owns the data?